Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get ABOS alerts

About Matthew Zuga

Matthew Zuga is recorded as CFO at Acumen Pharmaceuticals, Inc. (ABOS). The newest filing on record that lists Matthew Zuga as CFO at Acumen Pharmaceuticals, Inc. (ABOS) is dated April 23, 2026. The proxy statement of Acumen Pharmaceuticals, Inc. reports total compensation of $948,789 for Matthew Zuga in fiscal 2025, including a base salary of $486,993. Disclosed compensation is on record for 5 fiscal years. Matthew Zuga has spoken on 1 earnings call across 1 company, most recently for Acumen Pharmaceuticals, Inc. on March 26, 2024. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Dr. George Golumbeski (Chairman and Board Member), Russell Barton (COO) and 1 other.

Matthew Zuga on recent calls

“As a reminder, our full year 2023 financial results are available in the press release we issued this morning and in our 10-K we will file later today.”
CFO, Acumen Pharmaceuticals, Inc. Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Acumen Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Acumen Pharmaceuticals, Inc. (ABOS) $486,993 $948,789
2024 Acumen Pharmaceuticals, Inc. (ABOS) $468,263 $1,689,514
2023 Acumen Pharmaceuticals, Inc. (ABOS) $450,253 $1,606,289
2022 Acumen Pharmaceuticals, Inc. (ABOS) $429,836 $1,188,786
2021 Acumen Pharmaceuticals, Inc. (ABOS) $315,430 $778,831

Recent activity